A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone-Reference-Cited by-同舟云学术

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

Published:2015-06-29 Issue:2 Volume:152 Page:389-398
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Rakovitch Eileen,Nofech-Mozes Sharon,Hanna Wedad,Baehner Frederick L.,Saskin Refik,Butler Steven M.,Tuck Alan,Sengupta Sandip,Elavathil Leela,Jani Prashant A.,Bonin Michel,Chang Martin C.,Robertson Susan J.,Slodkowska Elzbieta,Fong Cindy,Anderson Joseph M.,Jamshidian Farid,Miller Dave P.,Cherbavaz Diana B.,Shak Steven,Paszat Lawrence

Funder

Canadian Cancer Society Research Institute

Genomic Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3464-6.pdf

Reference46 articles.

1. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R (2010) State-of-the-science conference: diagnosis and management of ductal carcinoma in situ (DCIS). J Natl Cancer Inst 102:161–169

2. Allred DC, Anderson SJ, Paik S, Wickerham DL, Nagtegaal ID, Swain SM, Mamounas EP, Julian TB, Geyer CE Jr, Costantino JP, Land SR, Wolmark N (2012) Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol 30:1268–1273. doi: 10.1200/JCO.2010.34.0141